Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3835

Full Length Research Paper

Quantitative proteomic analysis of Isorhamnetin treatment in human liver cancer cells

Runhuan Fei
  • Runhuan Fei
  • Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Gaotanyan Street 29, Shapingba District, Chongqing, People’s Republic of China.
  • Search for this author on:
  • Google Scholar
Haiyan Wei
  • Haiyan Wei
  • School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
  • Search for this author on:
  • Google Scholar


  •  Received: 26 January 2018
  •  Published: 17 February 2018

Abstract

Isorhamnetin (Iso) exhibits antitumor effects in promyelotic leukemia and lung cancers. However, its effect in liver cancer is not clear. This study explored the effects of Iso in human liver cancer cells and profiled the differential proteins upon Iso treatment, which contributes to a better understanding of its anticancer mechanisms. Stable isotope labeling with amino acids in cell culture-mass spectrometry: ESI-Iontrap (SILAC-MS) was used to study the differentially proteomic profile of Iso-treated HepG2 cells. Iso inhibits HepG2 cell proliferation in a dose-dependent manner.  A total of 84 proteins are identified, among which 7 proteins were up-regulated while 77 proteins were down-regulated. Iso inhibits HepG2 cell proliferation by the induction of apoptosis and the inhibition of protein synthesis of human liver cancer cell.

Key words:  Isorhamnetin, Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC), differential proteomic profile, HepG2 cells.

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 12 No. 7
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES